CLINICAL AND PARACLINICAL CHARACTERISTICS AND FACTORS ASSOCIATED WITH RECURRENT OR PERSISTENT HEMATOSPERMIA AT BINH DAN HOSPITAL

Bá Tiến Dũng Mai1,
1 Bệnh viện Bình Dân

Main Article Content

Abstract

Objective: To describe clinical, laboratory, and imaging characteristics and analyze factors associated with recurrent or persistent hematospermia among patients at Binh Dan Hospital.


Methods: A retrospective descriptive study with analytic components was conducted in 68 men aged 18 years or older attending the Andrology Department of Binh Dan Hospital from January 2024 to December 2025. Clinical, laboratory, and imaging data were obtained from electronic medical records; associations with recurrent/persistent hematospermia were examined in univariable analyses and expressed as crude odds ratios (ORs) with 95% confidence intervals (CIs).


Results: The median age was 46.0 (IQR 38.0–55.0) years. Recurrent or persistent hematospermia occurred in 64.7%, while 45.6% had no accompanying symptoms. Lower urinary tract symptoms (LUTS) and dysuria were present in 25.0% and 17.6%, respectively. Pyuria and microscopic hematuria were found in 14.7% and 11.8%. Among 60 patients undergoing transrectal ultrasonography (TRUS), 63.3% had at least one abnormality, most commonly prostatic calcification (28.3%). Age ≥40 years (OR=3.40; 95%CI: 1.17–9.88), LUTS (OR=5.69; 95%CI: 1.18–27.51), and abnormal TRUS findings (OR=3.22; 95%CI: 1.05–9.89) were associated with recurrent or persistent hematospermia.


Conclusion: In univariable analyses, age ≥40 years, LUTS, and abnormal TRUS findings were associated with recurrent or persistent hematospermia. These associations should be interpreted cautiously because of the retrospective design and lack of adjustment for potential confounders.

Article Details

References

1. Madhushankha M, Jayarajah U, Abeygunasekera AM. (2021). Clinical characteristics, etiology, management and outcome of hematospermia: a systematic review. Am J Clin Exp Urol, 9(1):1-17.
2. Suh Y, Gandhi J, Joshi G, Lee MY, Weissbart SJ, Smith NL, et al. (2017). Etiologic classification, evaluation, and management of hematospermia. Transl Androl Urol, 6(5):959-972.
3. Efesoy O, Çayan S, Aşcı R, Orhan İ, Yaman Ö. (2021). Hematospermia is rarely related to genitourinary cancer: lessons learned from 15 years of experience with 342 cases. Int J Impot Res, 33(6):627-633.
4. Satchi M, Katelaris A, Smekal M, Alnajjar HM, Muneer A. (2022). Detection rates of urogenital cancers and benign pathology in men presenting with hematospermia. Curr Urol, 16(1):44-49.
5. Harmath C, Allen BC, Turkbey B, et al. (2025). ACR Appropriateness Criteria® Hematospermia. J Am Coll Radiol, 22(11 Suppl):S539-S549.
6. Yagci C, Kupeli S, Tok C, Fitoz S, Baltaci S, Gogus O. (2004). Efficacy of transrectal ultrasonography in the evaluation of hematospermia. Clin Imaging, 28(4):286-290.
7. Han H, Lei HE, Zhang XD, Tian L. (2021). Magnetic resonance imaging compared to ultrasound as the preferred method for diagnosing intractable haematospermia. Andrologia, 53(6):e14054.
8. Furuya S, Masumori N, Takayanagi A. (2016). Natural history of hematospermia in 189 Japanese men. Int J Urol, 23(11):934-940.
9. Sivanandan S, Wijayarathna SN, Balagobi B, Kumara MGSR, Ambegoda ALAMC, Abeygunasekera AM. (2019). A prospective study on aetiology and outcome of haemospermia from a urology unit in Sri Lanka. J Clin Urol, 12(4):280-284.